Clinical Trials

If you have a potential patient, please call Kristin Mund, Clinical Research Manager at 405-713-4413.

Critical Care

  • NCT03384875 2017-001 REFRESH II Trial: “CytoSorb® Reduction of FREe Hemoglobin/Acute Kidney Injury (AKI) During Cardiac Surgery (REFRESH II Trial)”

INTEGRIS Advanced Cardiac Care

  • NCT02892955 MOMENTUM 3 CAP: “MOMENTUM 3 CAP Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy with HeartMate 3™ Continued Access Protocol”
  • NCT02232659: “SynCardia 70cc Temporary Total Artificial Heart (TAH-t) for Destination Therapy (DT)”
  • NCT02459054: “SynCardia 50cc Temporary Total Artificial Heart (TAH-t) as a Bridge to Transplant”
  • NCT02554903 AC-055-205 SOPRANO: “A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Macitentan in Patients with Pulmonary Hypertension after Left Ventricular Assist Device Implantation”
  • NCT02861534 1242-001 VICTORIA: “A Randomized Parallel-Group, Placebo-Controlled, Double-Blind, Event-Driven, Multi-Center Pivotal Phase III Clinical Outcome Trial of Efficacy and Safety of the Oral sGC Stimulator Vericiguat in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF) - Vericiguat Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA)”
  • NCT02816736 HFN-LIFE: “EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)”
  • NCT03387813 CIP-10170 GUIDE-HF: “Hemodynamic-GUIDEd Management of Heart Failure”
  • NCT02030418 DC-02374: “Safety and Effectiveness Trial for the Nanostim Leadless Pacemaker”